![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: ADAM8 |
Gene summary for ADAM8 |
![]() |
Gene information | Species | Human | Gene symbol | ADAM8 | Gene ID | 101 |
Gene name | ADAM metallopeptidase domain 8 | |
Gene Alias | CD156 | |
Cytomap | 10q26.3 | |
Gene Type | protein-coding | GO ID | GO:0000165 | UniProtAcc | P78325 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
101 | ADAM8 | P2T-E | Human | Esophagus | ESCC | 2.62e-04 | 1.44e-01 | 0.1177 |
101 | ADAM8 | P8T-E | Human | Esophagus | ESCC | 2.11e-03 | 1.57e-01 | 0.0889 |
101 | ADAM8 | P21T-E | Human | Esophagus | ESCC | 2.20e-04 | 1.50e-01 | 0.1617 |
101 | ADAM8 | P37T-E | Human | Esophagus | ESCC | 2.20e-02 | 1.33e-01 | 0.1371 |
101 | ADAM8 | P52T-E | Human | Esophagus | ESCC | 2.92e-02 | 1.24e-01 | 0.1555 |
101 | ADAM8 | P62T-E | Human | Esophagus | ESCC | 1.87e-05 | 2.35e-01 | 0.1302 |
101 | ADAM8 | P65T-E | Human | Esophagus | ESCC | 2.80e-02 | 1.10e-01 | 0.0978 |
101 | ADAM8 | P75T-E | Human | Esophagus | ESCC | 2.70e-09 | 1.96e-01 | 0.1125 |
101 | ADAM8 | P76T-E | Human | Esophagus | ESCC | 1.34e-11 | 1.86e-01 | 0.1207 |
101 | ADAM8 | P82T-E | Human | Esophagus | ESCC | 6.99e-05 | 3.37e-01 | 0.1072 |
101 | ADAM8 | P89T-E | Human | Esophagus | ESCC | 4.31e-04 | 7.74e-01 | 0.1752 |
101 | ADAM8 | P91T-E | Human | Esophagus | ESCC | 5.86e-08 | 1.03e+00 | 0.1828 |
101 | ADAM8 | P126T-E | Human | Esophagus | ESCC | 3.09e-02 | 4.91e-01 | 0.1125 |
101 | ADAM8 | P130T-E | Human | Esophagus | ESCC | 3.08e-28 | 6.12e-01 | 0.1676 |
101 | ADAM8 | C04 | Human | Oral cavity | OSCC | 2.16e-05 | 3.87e-01 | 0.2633 |
101 | ADAM8 | C21 | Human | Oral cavity | OSCC | 1.09e-30 | 1.21e+00 | 0.2678 |
101 | ADAM8 | C30 | Human | Oral cavity | OSCC | 1.39e-10 | 6.27e-01 | 0.3055 |
101 | ADAM8 | C38 | Human | Oral cavity | OSCC | 9.97e-03 | 2.88e-01 | 0.172 |
101 | ADAM8 | C43 | Human | Oral cavity | OSCC | 1.30e-20 | 4.56e-01 | 0.1704 |
101 | ADAM8 | C46 | Human | Oral cavity | OSCC | 1.37e-18 | 4.28e-01 | 0.1673 |
Page: 1 2 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0042176111 | Esophagus | ESCC | regulation of protein catabolic process | 280/8552 | 391/18723 | 8.65e-26 | 2.39e-23 | 280 |
GO:0022411111 | Esophagus | ESCC | cellular component disassembly | 305/8552 | 443/18723 | 1.94e-23 | 4.57e-21 | 305 |
GO:0009896111 | Esophagus | ESCC | positive regulation of catabolic process | 332/8552 | 492/18723 | 4.36e-23 | 9.22e-21 | 332 |
GO:0031331111 | Esophagus | ESCC | positive regulation of cellular catabolic process | 292/8552 | 427/18723 | 8.67e-22 | 1.53e-19 | 292 |
GO:0045862111 | Esophagus | ESCC | positive regulation of proteolysis | 256/8552 | 372/18723 | 7.88e-20 | 9.43e-18 | 256 |
GO:0045732111 | Esophagus | ESCC | positive regulation of protein catabolic process | 167/8552 | 231/18723 | 1.47e-16 | 1.14e-14 | 167 |
GO:1904951111 | Esophagus | ESCC | positive regulation of establishment of protein localization | 216/8552 | 319/18723 | 1.01e-15 | 6.86e-14 | 216 |
GO:0051222111 | Esophagus | ESCC | positive regulation of protein transport | 204/8552 | 303/18723 | 1.56e-14 | 8.38e-13 | 204 |
GO:007190016 | Esophagus | ESCC | regulation of protein serine/threonine kinase activity | 227/8552 | 359/18723 | 1.12e-11 | 4.10e-10 | 227 |
GO:0070482111 | Esophagus | ESCC | response to oxygen levels | 218/8552 | 347/18723 | 6.91e-11 | 2.17e-09 | 218 |
GO:005160418 | Esophagus | ESCC | protein maturation | 189/8552 | 294/18723 | 7.64e-11 | 2.39e-09 | 189 |
GO:0036293111 | Esophagus | ESCC | response to decreased oxygen levels | 201/8552 | 322/18723 | 8.37e-10 | 2.04e-08 | 201 |
GO:0001666111 | Esophagus | ESCC | response to hypoxia | 192/8552 | 307/18723 | 1.59e-09 | 3.69e-08 | 192 |
GO:0070997111 | Esophagus | ESCC | neuron death | 216/8552 | 361/18723 | 3.49e-08 | 6.45e-07 | 216 |
GO:004578527 | Esophagus | ESCC | positive regulation of cell adhesion | 255/8552 | 437/18723 | 5.07e-08 | 9.11e-07 | 255 |
GO:0071453110 | Esophagus | ESCC | cellular response to oxygen levels | 114/8552 | 177/18723 | 3.63e-07 | 5.06e-06 | 114 |
GO:0036294110 | Esophagus | ESCC | cellular response to decreased oxygen levels | 105/8552 | 161/18723 | 4.20e-07 | 5.73e-06 | 105 |
GO:00510908 | Esophagus | ESCC | regulation of DNA-binding transcription factor activity | 252/8552 | 440/18723 | 5.22e-07 | 6.97e-06 | 252 |
GO:00028318 | Esophagus | ESCC | regulation of response to biotic stimulus | 191/8552 | 327/18723 | 2.12e-06 | 2.45e-05 | 191 |
GO:00719029 | Esophagus | ESCC | positive regulation of protein serine/threonine kinase activity | 124/8552 | 200/18723 | 2.27e-06 | 2.61e-05 | 124 |
Page: 1 2 3 4 5 6 7 8 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
ADAM8 | SNV | Missense_Mutation | novel | c.2003T>C | p.Val668Ala | p.V668A | P78325 | protein_coding | tolerated(0.37) | benign(0.03) | TCGA-AZ-4315-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
ADAM8 | SNV | Missense_Mutation | rs539019756 | c.1189G>A | p.Ala397Thr | p.A397T | P78325 | protein_coding | tolerated(0.6) | benign(0.052) | TCGA-AZ-6598-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
ADAM8 | SNV | Missense_Mutation | rs373192234 | c.1460N>T | p.Pro487Leu | p.P487L | P78325 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-CK-5914-01 | Colorectum | colon adenocarcinoma | Male | >=65 | III/IV | Unknown | Unknown | SD |
ADAM8 | SNV | Missense_Mutation | novel | c.1880N>C | p.Gln627Pro | p.Q627P | P78325 | protein_coding | tolerated(0.14) | benign(0.007) | TCGA-CM-5861-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | PD |
ADAM8 | SNV | Missense_Mutation | rs759368536 | c.1717G>A | p.Ala573Thr | p.A573T | P78325 | protein_coding | deleterious(0.02) | probably_damaging(0.988) | TCGA-G4-6320-01 | Colorectum | colon adenocarcinoma | Male | >=65 | III/IV | Chemotherapy | oxaliplatin | SD |
ADAM8 | SNV | Missense_Mutation | novel | c.673C>T | p.Arg225Trp | p.R225W | P78325 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-G4-6320-01 | Colorectum | colon adenocarcinoma | Male | >=65 | III/IV | Chemotherapy | oxaliplatin | SD |
ADAM8 | SNV | Missense_Mutation | novel | c.1274N>C | p.Gly425Ala | p.G425A | P78325 | protein_coding | deleterious(0) | probably_damaging(0.994) | TCGA-G4-6586-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
ADAM8 | SNV | Missense_Mutation | novel | c.1727N>T | p.Thr576Ile | p.T576I | P78325 | protein_coding | tolerated(0.14) | benign(0.26) | TCGA-G4-6588-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
ADAM8 | SNV | Missense_Mutation | novel | c.1559N>A | p.Gly520Glu | p.G520E | P78325 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-G4-6588-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
ADAM8 | SNV | Missense_Mutation | novel | c.1735N>A | p.Gly579Ser | p.G579S | P78325 | protein_coding | tolerated(0.66) | benign(0.02) | TCGA-A5-A1OF-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 7 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
101 | ADAM8 | ENZYME, NEUTRAL ZINC METALLOPEPTIDASE, CELL SURFACE, DRUGGABLE GENOME, PROTEASE | inhibitor | 252166879 |
Page: 1 |